Loading…
Stevanato Group S.p.A. is projected to rise to $22.82 by 2027, a +16% move from its current price of $19.59. STVN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $19.18 | $19.59 | $20.01 | +0.01% |
| Jul 15 | $19.02 | $19.59 | $20.18 | +0.02% |
| Jul 16 | $18.89 | $19.59 | $20.32 | +0.02% |
| Jul 17 | $18.79 | $19.60 | $20.44 | +0.03% |
| Jul 18 | $18.70 | $19.60 | $20.54 | +0.04% |
| Jul 19 | $18.62 | $19.60 | $20.64 | +0.05% |
| Jul 20 | $18.54 | $19.60 | $20.72 | +0.06% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $18.54 | $19.60 | $20.72 | +0.06% |
| Week 2 | $18.13 | $19.61 | $21.22 | +0.12% |
| Week 3 | $17.82 | $19.62 | $21.61 | +0.17% |
| Week 4 | $17.57 | $19.64 | $21.95 | +0.23% |
| Week 5 | $17.35 | $19.65 | $22.25 | +0.29% |
| Week 6 | $17.15 | $19.66 | $22.53 | +0.35% |
| Week 7 | $16.98 | $19.67 | $22.79 | +0.41% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Stevanato Group S.p.A. is a healthcare company that designs, produces and distributes solutions for the biopharma and healthcare industries across Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical line equipment; and after-sales services such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices.
The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
Stevanato Group S.p.A. (STVN) is currently priced at $19.75 per share, with a market capitalization of $5.39B and a market rank of 1332.
The technical backdrop shows bullish momentum, with RSI(14) at 70, the SMA50 at $17.95 and the SMA200 at $19.22. Immediate support is at $16.51 and a key resistance level is at $19.75, with a 30-day price range of $17.13 to $22.78.
The forward forecast depicts upside potential over time. The 2026 average is $19.75, with higher averages evident in subsequent years, and an unfolding path toward larger targets by 2050. Notable yearly averages include 2027 $22.96, 2028 $25.56, 2029 $28.85, 2030 $34.11, 2031 $42.34, 2040 $92.27, and 2050 $171.02, reflecting rising sentiment and expected appreciation over the long term.
A major floor 31.4% below — a decisive break under it would weaken the trend.
The nearest floor, 15.7% below — buyers have tended to step in here.
Price is pressing into resistance (0.8% away) — a breakout level to watch.
A major ceiling 11.6% above — clearing it would confirm fresh momentum.
Key STVN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of STVN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $19.51 | Buy | $19.39 | Buy |
| MA 10 | $18.81 | Buy | $18.96 | Buy |
| MA 20 | $17.98 | Buy | $18.47 | Buy |
| MA 50 | $18.02 | Buy | $17.81 | Buy |
| MA 100 | $16.52 | Buy | $17.70 | Buy |
| MA 200 | $19.18 | Buy | $18.69 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 63.55 | Neutral |
| Stoch RSI (14) | 90.02 | Sell |
| CCI (20) | 113.03 | Buy |
| Williams %R (14) | -5.56 | Info |
| MACD (12,26,9) | 0.22 | Buy |
| ROC (12) | 16.12 | Buy |
| Bollinger %B (20,2) | 0.88 | Neutral |
| Stochastic %K (14) | 94.44 | Sell |
| TRIX (15) | 0.21 | Buy |
| Awesome (5,34) | 1.41 | Buy |
| Ultimate (7,14,28) | 73.54 | Sell |
| Momentum (10) | 1.20 | Buy |
| Aroon Osc (25) | 60.00 | Buy |
| Hull MA (9) | 19.90 | Sell |
| ADX (14) | 20.98 | Buy |
| ATR (14) | 0.38 | Info |
The 30-day technical picture is bullish, supported by an RSI of 70 and price action hovering near resistance at $19.75.
Moving averages show the 50-day at $17.95 and the 200-day at $19.22, framing a constructive short-term trend. The stock sits with a defined nearby resistance at $19.75 and a support level at $16.51, with the 30-day trading range between $17.13 and $22.78.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $13.43 | $19.59 | $25.45 | 0% | Neutral | |
| $18.55 | $22.82 | $29.43 | +16% | Neutral | |
| $20.34 | $25.55 | $33.94 | +30% | Bullish | |
| $22.65 | $28.94 | $39.35 | +48% | Bullish | |
| $26.35 | $34.18 | $47.39 | +74% | Bullish | |
| $32.39 | $42.60 | $60.09 | +117% | Bullish | |
| $34.46 | $45.90 | $65.77 | +134% | Bullish | |
| $35.05 | $47.25 | $68.66 | +141% | Bullish | |
| $39.36 | $53.66 | $78.98 | +174% | Bullish | |
| $40.34 | $55.59 | $82.82 | +184% | Bullish | |
| $64.92 | $93.87 | $147.17 | +379% | Bullish | |
| $111.61 | $174.93 | $295.68 | +793% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $13.43 | $19.59 | $23.64 | +0.00% |
| August 2026 | $17.00 | $19.94 | $23.92 | +1.77% |
| September 2026 | $16.74 | $19.74 | $23.89 | -1.00% |
| October 2026 | $17.07 | $20.22 | $24.66 | +2.44% |
| November 2026 | $17.42 | $20.72 | $25.42 | +2.46% |
| December 2026 | $17.28 | $20.63 | $25.45 | -0.42% |
Click any year to see its month-by-month STVN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The STVN price prediction for 2026 points to an average of $19.59 (low $13.43, high $25.45) — a potential gain of 0% on today's $19.59. Price action looks broadly range-bound.
In 2027, STVN is projected to trade between $18.55 and $29.43, averaging $22.82 — a potential gain of +16% from today's $19.59. That is up +16% on the projected 2026 average. A consolidation phase looks the most probable path here.
Stevanato Group S.p.A.'s 2028 outlook centres on $25.55, within a $20.34 to $33.94 range. That is up +12% on the projected 2027 average. That marks a +30% change versus current levels. Momentum favours further upside here.
By 2029, STVN could reach as high as $39.35, with a base case around $28.94 and support toward $22.65 — roughly +48% from $19.59. Buyers look set to stay in control over this stretch.
Expect STVN to range from $26.35 to $47.39 through 2030. The $34.18 average target implies a +74% move from current prices. That is up +18% on the projected 2029 average. Momentum favours further upside here.
The STVN price prediction for 2031 points to an average of $42.60 (low $32.39, high $60.09) — a potential gain of +117% on today's $19.59. Buyers look set to stay in control over this stretch.
In 2032, STVN is projected to trade between $34.46 and $65.77, averaging $45.90 — a potential gain of +134% from today's $19.59. That is up +8% on the projected 2031 average. Momentum favours further upside here.
Stevanato Group S.p.A.'s 2033 outlook centres on $47.25, within a $35.05 to $68.66 range. That is up +3% on the projected 2032 average. That marks a +141% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, STVN could reach as high as $78.98, with a base case around $53.66 and support toward $39.36 — roughly +174% from $19.59. Momentum favours further upside here.
Expect STVN to range from $40.34 to $82.82 through 2035. The $55.59 average target implies a +184% move from current prices. That is up +4% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The STVN price prediction for 2040 points to an average of $93.87 (low $64.92, high $147.17) — a potential gain of +379% on today's $19.59. Momentum favours further upside here.
In 2050, STVN is projected to trade between $111.61 and $295.68, averaging $174.93 — a potential gain of +793% from today's $19.59. That is up +86% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in STVN today (≈ 51.046452 STVN) could be worth
$8,929.77
+$7,929.77 (+793%) by 2050 · US Dollar
Based on the average projected STVN price of $174.93 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in STVNwould be worth at today's price.
$1,000 invested in STVN on Jul 10, 2025 (≈ 38.5505 STVN) would be worth
$755.2
-$244.8 (-24.5%) today · 0.76× · US Dollar
Based on a STVN entry price of $25.94 vs. today's $19.59.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $19 | $1,031.05 | +3.1% |
| 1 month ago | $17.25 | $1,135.65 | +13.6% |
| 3 months ago | $13.52 | $1,448.96 | +44.9% |
| 6 months ago | $20.73 | $945.01 | -5.5% |
| 1 year ago | $25.94 | $755.2 | -24.5% |
| All time (5.0y) ago | $19.67 | $995.93 | -0.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our STVN forecast.
Our base-case forecast reaches $39.00 around 2031.
Implied market cap at $39.00: $1.94B
The multi-year forecast outlines a clear path of higher averages and substantial upside by 2030 and beyond. By 2030, the average price is projected to $34.11 with a min of $26.19 and a max of $47.52, translating to a 72.7% ROI in that year and a bullish outlook.
The forecast accelerates further toward 2040, with an average of $92.27 and a min of $63.35 and max of $145.73, corresponding to a 367.2% ROI and a bullish sentiment.
By 2050, the average is projected at $171.02 with a min of $108.00 and max of $291.63, yielding a 765.9% ROI and a bullish sentiment. These figures indicate meaningful upside through the late 2020s and into the 2030s–2050 horizon, though they are estimates and not guarantees. Risks include market variability and other unpredictable factors that can affect outcomes.
Tap a question to reveal the answer.
Avg price $34.11, min $26.19, max $47.52, ROI 72.7%, sentiment BULLISH.
Forecasts show rising averages and bullish sentiment from 2028 onward, with 2030 average $34.11 and 2050 average $171.02, ROI 72.7% in 2030, 367.2% in 2040, and 765.9% in 2050; 2026 and 2027 are shown as NEUTRAL.
No. The 2030 max forecast is $47.52, which is below $50.
Current price is $19.75 and market cap is $5.39B.
Average price $92.27, min $63.35, max $145.73, ROI 367.2%, sentiment BULLISH.
Stevanato Group S.p.A. Community Discussion
0Share your Stevanato Group S.p.A. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.